Home/AI for Science/Chan Zuckerberg Biohub
EN↔中文
Company

Chan Zuckerberg Biohub

CZI Science merged with Biohub, absorbing the EvolutionaryScale team

Overview

This profile was compiled from the AI training-data column cards (AI for Science); each column's data view is shown below under "Data profile" (in Chinese).

Data profile · AI for Science

Chan Zuckerberg Biohub

CZI Science 与 Biohub 合并,并入 EvolutionaryScale 团队

做什么

2025-11 CZI Science 与 Biohub 网络合并重组,并入 EvolutionaryScale 团队(约 50 人),Alex Rives 任 head of science [1]。CZI 同时运营 CELLxGENE 与 Billion Cells 项目等公共数据资源。

资金与数据去向

资金来自 Zuckerberg/Chan 的慈善,属公共资金/慈善资金模式,无直接收入;产出数据与模型倾向开放。

争议与口径冲突

交易金额未披露;法律框架有"收购"与"团队加入"两种说法 [2]。EvolutionaryScale 的模型见 evolutionary-scale、esm3。在验证闭环语境下,慈善资金是 validation-as-service 之外的另一类验证出资方(见 vendors-policy)。

  1. https://www.axios.com/2025/11/06/zuckerberg-chan-biohub-ai-disease (2026-10-15)
  2. https://www.gunder.com/en/news-insights/client-news/gunderson-client-evolutionaryscale-team-joins-biohub-in-strategic-transaction-with-chan-zuckerberg-initiative (2026-10-15)
Last compiled: 2026-10-15